VolitionRX Ltd. (VNRX)
0.1621
0.00 (0.00%)
USD |
NYAM |
Nov 20, 16:00
0.1629
0.00 (0.00%)
After-Hours: 20:00
VolitionRX EPS Diluted (Quarterly) : -0.2065 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.2065 |
| June 30, 2026 | -0.8505 |
| March 31, 2026 | -0.9684 |
| December 31, 2025 | -1.026 |
| September 30, 2025 | -0.994 |
| June 30, 2025 | -1.224 |
| March 31, 2025 | -1.124 |
| December 31, 2024 | -1.206 |
| September 30, 2024 | -0.0662 |
| June 30, 2024 | -0.0845 |
| March 31, 2024 | -0.1021 |
| December 31, 2023 | -0.1072 |
| September 30, 2023 | -0.1071 |
| June 30, 2023 | -0.1416 |
| March 31, 2023 | -0.1459 |
| December 31, 2022 | -0.1251 |
| September 30, 2022 | -0.138 |
| June 30, 2022 | -0.1422 |
| March 31, 2022 | -0.142 |
| December 31, 2021 | -0.1505 |
| September 30, 2021 | -0.1342 |
| June 30, 2021 | -0.1044 |
| March 31, 2021 | -0.1201 |
| December 31, 2020 | -0.1057 |
| September 30, 2020 | -0.092 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.116 |
| March 31, 2020 | -0.142 |
| December 31, 2019 | -0.0865 |
| September 30, 2019 | -0.1048 |
| June 30, 2019 | -0.1069 |
| March 31, 2019 | -0.1161 |
| December 31, 2018 | -0.12 |
| September 30, 2018 | -0.14 |
| June 30, 2018 | -0.15 |
| March 31, 2018 | -0.17 |
| December 31, 2017 | -3.00 |
| September 30, 2017 | -3.00 |
| June 30, 2017 | -2.60 |
| March 31, 2017 | -0.13 |
| December 31, 2016 | -0.12 |
| September 30, 2016 | -0.15 |
| June 30, 2016 | -0.13 |
| March 31, 2016 | -0.13 |
| December 31, 2015 | -0.14 |
| September 30, 2015 | -0.16 |
| June 30, 2015 | -0.10 |
| March 31, 2015 | -0.12 |
| December 31, 2014 | -0.06 |
| September 30, 2014 | -0.44 |
| June 30, 2014 | 0.06 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PAVmed, Inc. | -1.770 |
| Owlet, Inc. | 0.0176 |
| Abbott Laboratories | 0.5294 |
| Align Technology, Inc. | 1.902 |
| AngioDynamics, Inc. | -0.1689 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.911M |
| Revenue (Quarterly) | 1.614M |
| Total Expenses (Quarterly) | 5.517M |
| Enterprise Value | 9.717M |
| Gross Profit Margin (Quarterly) | 83.80% |
| Profit Margin (Quarterly) | -242.3% |
| Earnings Yield | -1.88K% |
| Normalized Earnings Yield | -1696.92 |